Therapeutic methods and agents for treatment of myocardial infarction

The present disclosure relates generally to methods and agents for the treatment of myocardial infarction. More specifically, the present disclosure relates to the use of CD14 antagonist antibodies for the treatment of myocardial infarction. 本公开一般涉及用于治疗心肌梗塞的方法和试剂。更具体地，本公开涉及CD14拮抗剂抗体用于治疗心肌梗塞的用途。...

Full description

Saved in:
Bibliographic Details
Main Authors REDLICH GORDEN, ZIEGLER BERNHARD
Format Patent
LanguageChinese
English
Published 30.06.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates generally to methods and agents for the treatment of myocardial infarction. More specifically, the present disclosure relates to the use of CD14 antagonist antibodies for the treatment of myocardial infarction. 本公开一般涉及用于治疗心肌梗塞的方法和试剂。更具体地，本公开涉及CD14拮抗剂抗体用于治疗心肌梗塞的用途。
Bibliography:Application Number: CN202180061742